Implantation or Injectable Dosage Form New Animal Drugs; Zeranol
other · Food and Drug Administration · Rule · Published 2005-02-09 · Effective 2005-02-09 · 70 FR 6764
Document
Document number
05-2451
Federal Register citation
70 FR 6764
CFR reference
21 CFR 522
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2005-02-09
Effective date
2005-02-09
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of two supplemental new animal drug applications (NADAs) filed by Schering-Plough Animal Health Corp. The supplemental NADAs provide for the addition of statements to labeling of subcutaneous implants containing zeranol warning against the use of these products in calves to be processed for veal.